Deubiquitinase USP5 suppresses ferroptosis in lung adenocarcinoma by deubiquitinating and stabilizing GPX3.
- 1Department of Oncology Xiamen Haicang Hospital Xiamen Fujian China.
- 2Xiamen Cancer Hospital (The First Affiliated Hospital of Xiamen University (Haicang Campus)) Xiamen China.
Abstract
Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and has emerged as a promising therapeutic target in nonsmall cell lung cancer (NSCLC). However, the specific mechanisms by which nonsmall cell lung cancer cells evade ferroptosis remain to be further elucidated. We conducted integrative transcriptomic analyses of published NSCLC datasets to identify ubiquitin-specific proteases (USPs) potentially involved in the regulation of ferroptosis. Multiple USP proteins were screened and their prognostic significance evaluated, ultimately selecting USP5 for functional studies in two lung adenocarcinoma (LUAD) cell lines and patient-derived LUAD organoids. Following treatment with the ferroptosis inducer erastin, survival rates and metastatic capacity were assessed. Ferroptosis was evaluated by measuring established ferroptotic markers and examining mitochondrial ultrastructure. Protein interactions were investigated using mass spectrometry, immunoprecipitation, and GST pull-down assays. USP5 was significantly upregulated in LUAD tissues and correlated with poor patient prognosis. Functional experiments demonstrated that USP5 suppresses ferroptosis in LUAD cells treated with erastin, thereby promoting cell survival, proliferation, and invasiveness. Mechanistically, USP5 directly binds to and deubiquitinates GPX3, a key antioxidant enzyme, to enhance its stability. Rescue experiments confirmed that GPX3 is a functional mediator of USP5's ferroptosis-inhibitory role. These findings are further supported in patient-derived LUAD organoids. Our study identifies USP5 as a critical suppressor of ferroptosis in LUAD through its stabilization of GPX3, revealing a novel USP5-GPX3 regulatory axis that enables tumor resistance to oxidative stress. Targeting this pathway may represent a promising therapeutic strategy.
Related
- USP11 Drives Cerebral Ischemia–Reperfusion Injury Via Promoting Ferroptosis by Deubiquitinating and Stabilizing ASK1
- Esketamine induces ferroptosis and suppresses immune evasion in lung adenocarcinoma cells via the hsa_circ_0022392/miR-548b-3p/MAP7 axis.
- The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18
- METTL7B-Mediated m6A Modification of PLEKHA4 Suppresses Ferroptosis via Reducing AURKA Ubiquitination to Promote Papillary Thyroid Cancer Progression.
- Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression
BibTeX
@article{fan2026deubiquitinase,
title = {{Deubiquitinase USP5 suppresses ferroptosis in lung adenocarcinoma by deubiquitinating and stabilizing GPX3.}},
author = {Xin Fan and Yubiao Lin and Zhigao Zhen and Yingqin Gao and Wenhui Zhen and Siyuan Zeng and Yufei Ji and Kaida Huang and Shuitu Feng},
journal = {Journal of cell communication and signaling},
year = {2026},
month = oct,
doi = {10.1002/ccs3.70121},
url = {https://europepmc.org/article/MED/42927416},
note = {CC BY},
}
RIS
TY - JOUR
TI - Deubiquitinase USP5 suppresses ferroptosis in lung adenocarcinoma by deubiquitinating and stabilizing GPX3.
AU - Xin Fan
AU - Yubiao Lin
AU - Zhigao Zhen
AU - Yingqin Gao
AU - Wenhui Zhen
AU - Siyuan Zeng
AU - Yufei Ji
AU - Kaida Huang
AU - Shuitu Feng
PY - 2026
DA - 2026/10/24
JO - Journal of cell communication and signaling
DO - 10.1002/ccs3.70121
UR - https://europepmc.org/article/MED/42927416
AB - Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation and has emerged as a promising therapeutic target in nonsmall cell lung cancer (NSCLC). However, the specific mechanisms by which nonsmall cell lung cancer cells evade ferroptosis remain to be further elucidated. We conducted integrative transcriptomic analyses of published NSCLC datasets to identify ubiquitin-specific proteases (USPs) potentially involved in the regulation of ferroptosis. Multiple USP proteins were screened and their prognostic significance evaluated, ultimately selecting USP5 for functional studies in two lung adenocarcinoma (LUAD) cell lines and patient-derived LUAD organoids. Following treatment with the ferroptosis inducer erastin, survival rates and metastatic capacity were assessed. Ferroptosis was evaluated by measuring established ferroptotic markers and examining mitochondrial ultrastructure. Protein interactions were investigated using mass spectrometry, immunoprecipitation, and GST pull-down assays. USP5 was significantly upregulated in LUAD tissues and correlated with poor patient prognosis. Functional experiments demonstrated that USP5 suppresses ferroptosis in LUAD cells treated with erastin, thereby promoting cell survival, proliferation, and invasiveness. Mechanistically, USP5 directly binds to and deubiquitinates GPX3, a key antioxidant enzyme, to enhance its stability. Rescue experiments confirmed that GPX3 is a functional mediator of USP5's ferroptosis-inhibitory role. These findings are further supported in patient-derived LUAD organoids. Our study identifies USP5 as a critical suppressor of ferroptosis in LUAD through its stabilization of GPX3, revealing a novel USP5-GPX3 regulatory axis that enables tumor resistance to oxidative stress. Targeting this pathway may represent a promising therapeutic strategy.
SN - 1873-9601
SN - 1873-961X
ER -